Please login to the form below

Not currently logged in
Email:
Password:

Oliver Rausch to lead translational research partnership efforts at NIHR

Has experience at UCB, GSK and Cellzome

NIHR Dr Oliver RauschDr Oliver Rausch has been appointed programme director of the UK's National Institute for Health Research translational research partnerships.

As part of the NIHR's Office for Clinical Research Infrastructure (NOCRI), the partnerships was created to support collaboration between industry, the NHS and academia in early and exploratory research for products with the potential to have a direct effect on improving healthcare.

Efforts currently cover two areas, inflammatory respiratory disease and joint and related inflammatory diseases, both of which shall be overseen by Dr Rausch.

He brings industry experience to the role having spent the past 15 years working at pharma companies across Europe.

Most recently, he was VP biology at Cellzome, and he has further experience as director, new chemical entities biology at UCB and as an investigator with GlaxoSmithKline (GSK).

Prior to joining the industry, Dr Rausch was a postdoctoral scientist at the Institute of Cancer Research in London.

“Oliver's appointment will strengthen the development of the Partnerships and underpins NOCRI's commitment to clear and streamlined access to the UK's world-leading clinical research infrastructure,” said Mark Samuels, managing director of NOCRI.

14th September 2012

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....
Sharing patient stories for World Pulmonary Hypertension Day
For World Pulmonary Hypertension Day and we’re here to help raise awareness of pulmonary hypertension (PH) - a frequently under and misdiagnosed condition. Created in collaboration with the PH patient...